Literature DB >> 17182616

Modulation of DRAK2 autophosphorylation by antigen receptor signaling in primary lymphocytes.

Monica L Friedrich1, Meng Cui2, Jeniffer B Hernandez1, Brian M Weist1, Hilde-Marie Andersen1, Xiaowu Zhang3, Lan Huang4, Craig M Walsh5.   

Abstract

Death-associated protein-related apoptotic kinase-2 (DRAK2), a member of the death-associated protein-like family of serine/threonine kinases, is highly expressed in lymphoid organs and is a negative regulator of T cell activation. To investigate the regulation of DRAK2 activity in primary lymphocytes, we employed mass spectrometry to identify sites of autophosphorylation on DRAK2. These studies have revealed a key site of autophosphorylation on serine 12. Using a phospho-specific antibody to detect Ser(12) phosphorylation, we found that autophosphorylation is induced by antigen receptor stimulation in T and B cells. In Jurkat T cells, resting B cells and thymocytes, DRAK2 was hypophosphorylated on Ser(12) but rapidly phosphorylated with antigen receptor ligation. This increase in phosphorylation was dependent on intracellular calcium mobilization, because BAPTA-AM blocked DRAK2 kinase activity, whereas the SERCA inhibitor thapsigargin promoted Ser(12) phosphorylation. Our results show that DRAK2 kinase activity is regulated in a calcium-dependent manner and that Ser(12) phosphorylation is necessary for optimal suppression of T cell activation by this kinase, suggesting a potential feedback loop may act to modulate the activity of this kinase following antigen receptor signaling.

Entities:  

Mesh:

Substances:

Year:  2006        PMID: 17182616     DOI: 10.1074/jbc.M606675200

Source DB:  PubMed          Journal:  J Biol Chem        ISSN: 0021-9258            Impact factor:   5.157


  8 in total

1.  Protein kinase D orchestrates the activation of DRAK2 in response to TCR-induced Ca2+ influx and mitochondrial reactive oxygen generation.

Authors:  Ryan H Newton; Sabrina Leverrier; Sonal Srikanth; Yousang Gwack; Michael D Cahalan; Craig M Walsh
Journal:  J Immunol       Date:  2010-12-10       Impact factor: 5.422

2.  A role for DRAK2 in the germinal center reaction and the antibody response.

Authors:  Ahmed Al-Qahtani; Zhenming Xu; Hong Zan; Craig M Walsh; Paolo Casali
Journal:  Autoimmunity       Date:  2008-08       Impact factor: 2.815

3.  Enhanced T cell apoptosis within Drak2-deficient mice promotes resistance to autoimmunity.

Authors:  Stephanie J Ramos; Jeniffer B Hernandez; Martina Gatzka; Craig M Walsh
Journal:  J Immunol       Date:  2008-12-01       Impact factor: 5.422

4.  Altered thymic selection and increased autoimmunity caused by ectopic expression of DRAK2 during T cell development.

Authors:  Martina Gatzka; Ryan H Newton; Craig M Walsh
Journal:  J Immunol       Date:  2009-07-01       Impact factor: 5.422

5.  Drak2 contributes to West Nile virus entry into the brain and lethal encephalitis.

Authors:  Shuhui Wang; Thomas Welte; Maureen McGargill; Terrence Town; Jesse Thompson; John F Anderson; Richard A Flavell; Erol Fikrig; Stephen M Hedrick; Tian Wang
Journal:  J Immunol       Date:  2008-08-01       Impact factor: 5.422

6.  Expression of miR-142-5p in peripheral blood mononuclear cells from renal transplant patients with chronic antibody-mediated rejection.

Authors:  Richard Danger; Chloé Paul; Magali Giral; Amélie Lavault; Yohann Foucher; Nicolas Degauque; Annaïck Pallier; Maxim Durand; Stéphanie Castagnet; Jean-Paul Duong Van Huyen; Michel Delahousse; Karine Renaudin; Jean-Paul Soulillou; Sophie Brouard
Journal:  PLoS One       Date:  2013-04-05       Impact factor: 3.240

Review 7.  Modulation of T Cell Metabolism and Function through Calcium Signaling.

Authors:  Kelley M Fracchia; Christine Y Pai; Craig M Walsh
Journal:  Front Immunol       Date:  2013-10-11       Impact factor: 7.561

8.  Phosphokinome Analysis of Barth Syndrome Lymphoblasts Identify Novel Targets in the Pathophysiology of the Disease.

Authors:  Prasoon Agarwal; Laura K Cole; Abin Chandrakumar; Kristin D Hauff; Amir Ravandi; Vernon W Dolinsky; Grant M Hatch
Journal:  Int J Mol Sci       Date:  2018-07-12       Impact factor: 5.923

  8 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.